For those with moderate-to-severe chronic heart failure, treatment options are limited. But a newly approved device may help.

New research shows that getting an annual flu shot reduces the risk of premature death from heart failure, particularly in patients 65 and older who already have compromised circulation and other health complications.

He may have heart failure, but Rev. Adam Leeper also has a great sense of humor. Learn how Adam has incorporated exercise into his lifestyle to help him manage his condition.

Mortality rates from heart failure are higher in women than in men, and the rate of hospitalization related to heart failure has risen among women but declined among men, according to a study conducted at the University of Ottawa Heart Institute.

Researchers evaluated heart failure risk in adults who were adopted to assess the impact of genetic and environmental factors on heart failure risk.

Latest approved heart drug, called an ARNI, lowers blood pressure and prevents hospitalization and death from heart failure.

Learn more about the different types of heart failure that are caused by cardiovascular disease and how they are diagnosed and treated.

Learn more about advances in treatment for congestive heart failure (CHF), which include various medicines, implantable devices, and new wearable technology.

For many people with chronic heart failure, two new drugs, Entresto and Corlanor, might help cut the risk of a hospital stay and possibly prolong their lives.

We explore who is most at risk and new heart failure treatment options that can improve quality of life and recovery.